DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 09 · Volume 52 · September 2014 DOI: 10.1055/s-004-27678


42. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V.
Augsburg, 23.–24. Oktober 2014

Präsident: Prof. Dr. H. Messmann, Klinikum Augsburg

  • G1
    Posselt, L; Lazic, I; Funk, A; Kirchleitner, S; Schievenbusch, S; Adunka, T; Endres, S; Düwell, P; Rothenfusser, S; Schnurr, M:

    Targeting RIG-I with 5'ppp-modified RNA for immunotherapy of hepatocellular carcinoma (HCC)

  • G2
  • G3
  • G4
    Wohlfahrt, J; Fettelschoss, A; Kündig, T; Hermanns, H; Müllhaupt, B; Schmitt, J; Geier, A:

    Beneficial Effects on Hepatic Steatosis in a Murine Obesity Model after IL-1 Type Cytokine Inactivation

  • G5
  • G6
    De Toni, EN; Lu, S; Liebl, J; Rizzani, A; Göke, B; Gallmeier, E; Vollmar, AM; Gerbes, AL:

    Antiproliferative and proapoptotic effect of the MLK/JNK inhibitor CEP-1347 in hepatocellular carcinoma